Literature DB >> 10995414

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina.

S Talwar1, I B Squire, P F Downie, J E Davies, L L Ng.   

Abstract

OBJECTIVE: To compare circulating concentrations of N terminal pro-brain natriuretic peptide (N-BNP) and cardiotrophin 1 in stable and unstable angina. DESIGN AND
SETTING: Observational study in a teaching hospital. PATIENTS: 15 patients with unstable angina, 10 patients with stable angina, and 15 controls. MAIN OUTCOME MEASURES: Resting plasma N-BNP and cardiotrophin 1 concentrations.
RESULTS: N-BNP concentration (median (range)) was 714 fmol/ml (177-3217 fmol/ml) in unstable angina, 169.5 fmol/ml (105.7-399.5 fmol/ml) in stable angina (p = 0.005 v unstable angina), and 150.5 fmol/ml (104. 7-236.9 fmol/ml) in controls (p < 0.0001 v unstable angina; NS v stable angina). Cardiotrophin 1 concentration was 142.5 fmol/ml (42. 2-527.4 fmol/ml) in unstable angina, 73.2 fmol/ml (41.5-102.1 fmol/ml) in stable angina (p < 0.05 v unstable angina), and 27 fmol/ml (6.9-54.1 fmol/ml) in controls (p < 0.0005 v stable angina; p < 0.0001 v unstable angina). Log cardiotrophin 1 correlated with log N-BNP in unstable angina (r = 0.93, p < 0.0001).
CONCLUSIONS: Both circulating N-BNP and cardiotrophin 1 are raised in unstable angina, while cardiotrophin 1 alone is raised in stable angina. The role of cardiotrophin 1 and the relation between cardiotrophin 1 and N-BNP in myocardial ischaemia remain to be defined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995414      PMCID: PMC1729429          DOI: 10.1136/heart.84.4.421

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy.

Authors:  Z Sheng; K Knowlton; J Chen; M Hoshijima; J H Brown; K R Chien
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

2.  Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide.

Authors:  K Nakao; M Mukoyama; K Hosoda; S Suga; Y Ogawa; Y Saito; G Shirakami; H Arai; M Jougasaki; H Imura
Journal:  Can J Physiol Pharmacol       Date:  1991-10       Impact factor: 2.273

3.  Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.

Authors:  P J Hunt; E A Espiner; M G Nicholls; A M Richards; T G Yandle
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

4.  Endothelin-1 and cardiotrophin-1 induce brain natriuretic peptide gene expression by distinct transcriptional mechanisms.

Authors:  K Kuwahara; Y Saito; Y Ogawa; N Tamura; M Ishikawa; M Harada; E Ogawa; Y Miyamoto; I Hamanaka; S Kamitani; N Kajiyama; N Takahashi; O Nakagawa; I Masuda; K Nakao
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

5.  An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure.

Authors:  S Talwar; P F Downie; I B Squire; D B Barnett; J D Davies; L L Ng
Journal:  Biochem Biophys Res Commun       Date:  1999-08-11       Impact factor: 3.575

6.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.

Authors:  S Talwar; I B Squire; J E Davies; D B Barnett; L L Ng
Journal:  Eur Heart J       Date:  1999-12       Impact factor: 29.983

7.  Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.

Authors:  K Kikuta; H Yasue; M Yoshimura; E Morita; H Sumida; H Kato; K Kugiyama; H Ogawa; K Okumura; Y Ogawa; K Nakao
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

8.  Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats.

Authors:  H Jin; R Yang; A Ko; D Pennica; W I Wood; N F Paoni
Journal:  Cytokine       Date:  1998-01       Impact factor: 3.861

9.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

Authors:  T G Yandle; A M Richards; A Gilbert; S Fisher; S Holmes; E A Espiner
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

10.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.

Authors:  D Pennica; K L King; K J Shaw; E Luis; J Rullamas; S M Luoh; W C Darbonne; D S Knutzon; R Yen; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more
  19 in total

1.  B Type natriuretic peptide: a good omen in myocardial ischaemia?

Authors:  S P D'Souza; G F Baxter
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

2.  Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.

Authors:  Ibrahim Altun; Burak Pamukcu; Cenk Eray Yildiz; Selda Can Arkaya; Goksel Guz; Akar Yilmaz; Ahmet Kaya Bilge; Umit Mutlu Turkoglu; Kamil Adalet
Journal:  Bosn J Basic Med Sci       Date:  2015-07-23       Impact factor: 3.363

3.  Level Of Natriuretic Peptide Determines Outcome In Atrial Fibrillation.

Authors:  Qi-Xian Zeng; Ming-Fen Wei; Wei Zhang; Yun Zhang; Jing-Quan Zhong
Journal:  J Atr Fibrillation       Date:  2010-01-01

4.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

5.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.

Authors:  Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

6.  Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

Authors:  Darren H Freed; Michael C Moon; Anna M Borowiec; Stephen C Jones; Peter Zahradka; Ian M C Dixon
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 7.  Natriuretic peptide hormone measurement in acute coronary syndromes.

Authors:  Param Maewal; James A de Lemos
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

8.  Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma.

Authors:  Jiang-Long Hou; Ke Gao; Mei Li; Jian-Yang Ma; Ying-Kang Shi; Yun Wang; Yong-Fan Zhao
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

9.  A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Authors:  Ming Dong; James K Liao; Bryan Yan; Ruijie Li; Mang Zhang; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2012-08-24       Impact factor: 4.164

10.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.